Since intestinal mucosal CD4+ T cells are being increasingly studied under disease conditions (e.g. inflammatory bowel disease and HIV), it is important to rigorously investigate the baseline mucosal immune environment throughout the gut in healthy individuals. The gene discussed is CD4; the disease is inflammatory bowel disease.